Utilising Flexibilities In The TRIPs Agreement January 2019 To Advance Access To Medicine In Kenya And Uganda
|Version||1 Previous versions
|Date added||March 18, 2021|
The Center for Health, Human rights and Development(CEHURD) in partnership with Kenya Legal and Ethical Issues Network on HIV and AIDS (KELIN) and Aidsfonds conducted a study on the “Utilization of Flexibilities in the TRIPs Agreement to Advance Access to Medicines in Kenya and Uganda”
The Agreement on Trade-Related Intellectual Property Rights (TRIPs) set minimum standards for protection of intellectual property rights (IPRs) for all fields of technology, including the pharmaceutical sector. However, to limit the potential effects of strong IPR protection on access to medicines, the agreement provides for a set of flexibilities, including compulsory licensing, parallel importation, and a transition period during which least developed countries (LDCs) do not have to grant patents on pharmaceuticals.
Download the study for more details..